S

Surrozen

83 employees

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Tissue repair
Liver Failure
Wnt Pathway
Health Care
Emergency Medicine
Regenerative medicine

Date founded

2016

Funding rounds raised

Total raised

$120M

from 8 investors over 8 rounds

S

Surrozen raised $120M on August 12, 2021

Investors: Consonance Capital and The Column Group

S

Surrozen raised $50M on June 19, 2020

Investors: Horizons Ventures and The Column Group

S

Surrozen raised $50M on March 15, 2019

Investors: NS Investment, The Column Group and Horizons Ventures

S

Surrozen raised $33M on February 15, 2017

Investors: The Column Group

FAQ